EPTRI has been implementing a Gender Equality Plan for 2024-2026, included in EPTRI’s Equality, Diversity and Inclusion strategy. This reaffirms its alignment with the 2030 Agenda and the Sustainable Development Goals. The Plan consists of 12 focus areas which aim...
admin_eptri
Home /
EPTRI General Assembly & Scientific Meeting
We are happy to announce that our General Assembly and Scientific Meeting held on 18 and 19 of July in Bari, Italy and online were a success! We counted with about 250 participants both in person and online that learned about EPTRI's evolution story from a European...
Sixth webinar on Child Health Data and Artificial Intelligence
The 6th webinar on Child Health Data and Artificial Intelligence organized by the EPTRI Medical Devices Platform was held online on 25th June of 2024. Participants had the chance to learn more about the impact of partnerships and co-design in shaping child health...
EPTRI represented at the PDCO in Belgium
Our president, Karel Allegaert, participated in the paediatric committee (PDCO) scientific meeting related to the Belgian presidency that was held last week in Leuven. Related to the ongoing revision of the EMA guideline on neonatal clinical studies, Karel discussed...
Fifth webinar on Co-design in Child Health Technology
The 5th webinar on Co-design in Child Health Technology organized by the EPTRI Medical Devices Platform was held online on 7th May of 2024. Participants had the chance to learn more about the impact of partnerships and co-design in shaping child health technology...
New research paper!
Donato Bonifazi and Adriana Ceci, both members of our Board of Directors, have co-authored the research paper entitled: “Innovative research methodologies in the EU regulatory framework: an analysis of EMA qualification procedures from a pediatric perspective”,...
Interview with the expert – ATMPs as Therapy Options in Europe
Based on the current political developments in Europe and the formulation of a National Strategy for Rare Diseases there is a need to provide suitable therapeutic options to underserved populations such as paediatric population and people living with rare diseases....
ENVI POSITION FOR THE NEW PHARMACEUTICAL LEGISLATION: WHAT’S NEW FOR PAEDIATRICS?
On 19 March, the Committee on the Environment, Public Health and Food Safety (ENVI), as the committee responsible for the procedure, adopted its position on the new Directive and Regulation on medicinal products for human use. MEPs agreed on a number of...
Establishment of EPTRI AISBL as a legal entity
We are very happy to announce that incorporated in the form of an Association International Sans But Lucrative (AISBL). The approval was granted by the Belgium Government as EPTRI is based in Leuven. This means that EPTRI can now apply to grants and other funding as...
OrphaDev4Kids project approved
We are excited to announce that the proposal OrphaDev4Kids has been approved. This collaborative project aims to address the issue of Orphan medical devices (MDs) to be used in the paediatric population. Paediatric MDs development is more complex and riskier for...